Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Hong Kongese chemical industry news
26 March 2026
KazMunayGas 2025 Financial Results
Revenue +12.5% to 9,371 bln KZT; EBITDA +19.6% to 2,393 bln; net profit down to 1,072 bln; net debt cut to 375 bln; production +10%; FCF +2.8%
25 March 2026
Novo Nordisk: UBT251 reduced HbA1c up to 2.16% at 24 weeks in Chinese Phase 2 T2D trial
Triple-agonist UBT251 (GLP-1/GIP/glucagon) induced up to 9.8% weight loss, improved BP and lipids vs placebo/semaglutide. Safety consistent with triple-G class; global phase-2 and China phase-3 planned
23 March 2026
GSK’s risvutatug rezetecan granted orphan drug designation for SCLC in Japan
Risvutatug rezetecan, a B7-H3–targeted ADC, showed durable responses in extensive‑stage SCLC in phase I ARTEMIS‑001; global phase III in relapsed ES‑SCLC is underway.
17 March 2026
Brenntag opens Life Sciences Innovation Center in Shanghai
Expands application expertise for Beauty & Care and Food & Nutrition; offers formulation development, testing, small-batch trials and product concept support for China & Hong Kong clients.
3 March 2026
GSK Finalizes RAPT Therapeutics Acquisition
GSK acquires ozureprubart, a potential long-acting anti-IgE therapy for food allergies, with phase IIb data expected in 2027. The deal is valued at $2.2 billion.
31 October 2025
KMG Eurobonds Begin Trading on AIX
KMG debuts in the yuan market with Dim Sum bonds on AIX, diversifying funding and expanding its investor base. The issuance attracted high investor interest and positive analyst reviews.
How does the Hong Kongese chemical industry perform?
Find out with
chemXplore Alpha
Learn more